Zihan Xu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 7
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 9
- Lung Cancer Research Studies 6
- Cancer Diagnosis and Treatment 5
-
- Immunotherapy and Immune Responses 7
-
- Ferroptosis and cancer prognosis 5
-
- RNA modifications and cancer 5
- Co-authors
- Mingjing ChenShuang DaiFeng LuoJianguo SunQiao YangLinpeng ZhengFeng LiLi Wang
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Zihan Xu
77 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 317
- Oncology 442
- Immunology 168
- Pulmonary and Respiratory Medicine 248
- Molecular Biology 508
Countries citing papers authored by Zihan Xu
This map shows the geographic impact of Zihan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zihan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zihan Xu more than expected).
Fields of papers citing papers by Zihan Xu
This network shows the impact of papers produced by Zihan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zihan Xu. The network helps show where Zihan Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zihan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 5 | |
| 10 | 2024 | 12 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 10 | |
| 13 | 2022 | 6 | |
| 14 | 2022 | 6 | |
| 15 | 2022 | 76 | |
| 16 | 2021 | 29 | |
| 17 | 2020 | 36 | |
| 18 | 2020 | 16 | |
| 19 | 2019 | 12 | |
| 20 | 2018 | 55 |
About Zihan Xu
Zihan Xu is a scholar working on Cancer Research, Oncology and Immunology, having authored 88 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers), Immunotherapy and Immune Responses (7 papers), Lung Cancer Research Studies (6 papers), Cancer Diagnosis and Treatment (5 papers), RNA modifications and cancer (5 papers) and Ferroptosis and cancer prognosis (5 papers). The work is most often cited by research in Cancer Research (317 citations), Oncology (442 citations) and Immunology (168 citations). Zihan Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Mingjing Chen, Shuang Dai, Feng Luo, Jianguo Sun, Qiao Yang, Linpeng Zheng, Feng Li, Li Wang, Yongxin Yu and Feng Luo. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.